Q3 2013 13F Holders as of 30 Sep 2013
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
1,458,057
-
Shares change
-
+796,118
-
Total reported value, excl. options
-
$456,100,415
-
Value change
-
+$249,187,180
-
Number of buys
-
10
-
Number of sells
-
-5
-
Price
-
$312.87
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q3 2013
20 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2013.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,458,057 shares
of 104,986,330 outstanding shares and own 1.4% of the company stock.
Largest 10 shareholders include WELLS FARGO & COMPANY/MN (634,489 shares), Citadel Advisors LLC (383,572 shares), Partner Fund Management, L.P. (242,922 shares), Retirement Systems of Alabama (46,393 shares), Zurcher Kantonalbank (Zurich Cantonalbank) (36,246 shares), HARTFORD INVESTMENT MANAGEMENT CO (22,768 shares), Partner Investment Management, L.P. (18,215 shares), PDT Partners, LLC (13,954 shares), State of Tennessee, Treasury Department (13,500 shares), and DIAM Co., Ltd. (12,996 shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.